Section Arrow
NEO.NASDAQ
- NeoGenomics
Quotes are at least 15-min delayed:2024/09/28 16:04 EDT
Last
 14.5
-0.14 (-0.96%)
Day High 
15.07 
Prev. Close
14.64 
1-M High
16.77 
Volume 
821.02K 
Bid
14
Ask
14.5
Day Low
14.445 
Open
14.84 
1-M Low
14.63 
Market Cap 
1.88B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 15.91 
20-SMA 15.96 
50-SMA 16.03 
52-W High 21.22 
52-W Low 11.03 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.62/-0.61
Enterprise Value
2.48B
Balance Sheet
Book Value Per Share
7.15
Cash Flow
Cash Flow Yield
0.00
Income Statement
Total Revenue
591.64M
Operating Revenue Per Share
3.54
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ME23andMe Holding Co0.2941-0.0241-7.57%-- 
OPKOPKO Health1.52+0.03+2.01%-- 
MYNZMainz Biomed NV0.247+0.0331+15.47%-- 
AAgilent Technologies148.06+1.32+0.90%30.51PE
QGENQiagen NV45.24+0.22+0.49%130.2PE
Quotes are at least 15-min delayed:2024/09/28 16:04 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.